BiotechTube

Bydureon BCise (exenatide extended release) + Semaglutide, 1.0 mg/mL

Phase 1Completed
0 watching 0 views this week💤 Quiet
25
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Overweight and Obesity

Conditions

Overweight and Obesity, Type2diabetes

Trial Timeline

Dec 20, 2024 → Aug 21, 2025

NCT ID
NCT05670379

About Bydureon BCise (exenatide extended release) + Semaglutide, 1.0 mg/mL

Bydureon BCise (exenatide extended release) + Semaglutide, 1.0 mg/mL is a phase 1 stage product being developed by Vivani Medical for Overweight and Obesity. The current trial status is completed. This product is registered under clinical trial identifier NCT05670379. Target conditions include Overweight and Obesity, Type2diabetes.

Hype Score Breakdown

Clinical
10
Activity
5
Company
2
Novelty
3
Community
2

Clinical Trials (1)

NCT IDPhaseStatus
NCT05670379Phase 1Completed

Competing Products

20 competing products in Overweight and Obesity

See all competitors
ProductCompanyStageHype Score
TERN-601Terns PharmaceuticalsPhase 2
49
LY3457263 + Tirzepatide + PlaceboEli LillyPhase 1
33
LY3305677 + PlaceboEli LillyPhase 1
33
LY3537031 + PlaceboEli LillyPhase 1
33
Tirzepatide + Lisdexamfetamine Dimesylate + Placebo (oral) + Placebo (injection)Eli LillyPhase 2
52
Eloralintide + PlaceboEli LillyPhase 3
77
LY4064912 + LY4064912 + Placebo + PlaceboEli LillyPhase 1
33
LY3437943 + Ethinyl Estradiol + DrospirenoneEli LillyPhase 1
33
Tirzepatide + AcetaminophenEli LillyPhase 1
33
Tirzepatide + PlaceboEli LillyPhase 2
52
Eloralintide + PlaceboEli LillyPhase 3
77
LY3437943 + PlaceboEli LillyPhase 1
33
LY3502970 + PlaceboEli LillyPhase 1
33
Tirzepatide + PlaceboEli LillyPhase 3
77
Eloralintide and Tirzepatide + EloralintideEli LillyPhase 1
33
Tirzepatide + PlaceboEli LillyPhase 3
77
LY3541105 + PlaceboEli LillyPhase 1
33
Retatrutide + PlaceboEli LillyPhase 2
52
LY4167586 + Placebo + LY4167586Eli LillyPhase 1
33
AZD9550 + AZD6234 + Placebo comparatorAstraZenecaPhase 2
52

Other Products from Vivani Medical

Semaglutide (Wegovy) weekly injectionPhase 1
25